GENDER FEATURES OF MYOCARDIAL STRUCTURAL AND FUNCTIONAL CHANGES IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS AT THE PREDIALYSIS STAGE OF THE DISEASE
DOI: https://doi.org/10.29296/25877305-2018-01-03
Issue:
1
Year:
2018
Male patients with glomerulonephritis at the predialysis stage of chronic kidney disease show a predominance of concentric left ventricular hypertrophy that is associated with the development of clinically significant cardiac arrhythmias. Whereas female patients with chronic glomerulonephritis have a lower glomerular filtration rate, anemia, a higher frequency of eccentric left ventricular hypertrophy and supraventricular ectopic activity.
Keywords:
nephrology
gender differences
chronic glomerulonephritis
chronic kidney disease
cardiovascular events
References:
- Muhin N.A. Nefrologija. Natsional'noe rukovodstvo. Kratkoe izdanie / M.: GEOTAR-Med, 2016; s. 608.
- Brück K., Stel V., Gambaro G. et al. CKD prevalence varies across the European general population // J. Am. Soc. Nephrol. – 2016; 27 (7): 2135–47. DOI:10.1681/ASN.2015050542.
- Yuan J., Zou X., Han S. et al. and on behalf of the C-STRIDE study group. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the chinese cohort study of chronic kidney disease (C-STRIDE) // BMC Nephrol. – 2017; 18: 23. DOI:10.1186/s12882-017-0441-9.
- Moiseev V.S., Muhin N.A., Smirnov A.V. Serdechno-sosudistyj risk i hronicheskaja bolezn' pochek: strategii kardionefroprotektsii // Ros. kardiol. zhurn. – 2014; 8: 7–37.
- Tong J., Liu M., Li H. et al. Mortality and Associated Risk Factors in Dialysis Patients with Cardiovascular Disease // Kidney Blood Press Res. – 2016; 41: 479–87. DOI:10.1159/000443449.
- Hill N., Fatoba S., Oke J. et al. Global Prevalence of Chronic Kidney Disease–A Systematic Review and Meta-Analysis // PloS One. – 2016; 11 (7): e0158765. DOI: http://dx.doi.org/10.1371/journal.pone.0158765.
- Snaedal S., Axelsson J., Machowska A. et al. Markers of inflammation and cardiovascular disease in dialysis patients: variability and prognostic value / Stockholm: Karolinska University Hospital, 2016; 8: 1–10.
- Tareeva I.E. Nefrologija. Rukovodstvo dlja vrachej. 2-e izd., pererab. i dop. / M.: Meditsina, 2000; 688.
- Levey A., Stevens L., Schmid C. et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate // Ann. Intern. Med. – 2009; 150 (9): 604–12. PMID:19414839.
- 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // Blood Press. – 2013; 22: 193–278. DOI: http://dx.doi.org/10.3109/08037051.2013.812549
- Devereux R., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method // Circulation. – 1977; 55 (4): 613–8. PMID:138494.
- Sato Y., Fujimoto S., Konta T. et al. Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease // Clin. Exp. Nephrol. – 2017. DOI:10.1007/s10157-017-1468-8.
- Atkinson M., Warady B. Anemiainchronic kidney disease // Pediatr. Nephrol. – 2017. DOI: 10.1007/s00467-017-3663-y.
- Murkamilov I.T., Ajtbaev K.A., Bajsymakova F.K. i dr. Faktory, sposobstvujuschie progressirovaniju glomerulonefritov i serdechno-sosudistyh narushenij // Zhurnal zdorov'e i obrazovanie v XXI veke. – 2017; 19 (8): 32–9.
- Ryu S., Park S., Jung J. et al. The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) // J. Korean Med. Sci. – 2017; 32 (2): 249–56. DOI:https://doi.org/10.3346/jkms.2017.32.2.249.
- Eckardt K., Gillespie I., Kronenberg F. et al. ARO Steering Committee: High cardiovascular event rates occur within the first weeks of starting hemodialysis // Kidney Int. – 2015; 88: 1117–25. DOI: http://dx.doi.org/10.1038/ki.2015.117.
- Goldberg I., Krause I. The Role of Gender in Chronic Kidney Disease // EMJ. – 2016; 1 (2): 58–64.
- Locatelli F., Marcelli D., Conte F. et al. Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi eTrapianto // Nephrol. Dial. Transplant. – 2000; 15 (Suppl. 5): 69–80.
- Herzog C., Asinger R., Berger A. et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) // Kidney Int. – 2011; 80 (6): 572–86. DOI: 10.1038/ki.2011.223.
- Volgina G.V. Klinicheskaja epidemiologija kardiovaskuljarnyh narushenij pri hronicheskoj pochechnoj nedostatochnosti // Nefrol. i dializ. – 2000; 2 (1–2): 25–32.
- Ali A., Macphee I., Kaski J. et al. Cardiac and vascular changes with kidney transplantation // Indian J. Nephrol. – 2016; 26 (1): 1–9. DOI:10.4103/0971-4065.165003.
- McCullough P., Roberts W. Influence of chronic renal failure on cardiac structure // J Am. Coll. Cardiol. – 2016; 67 (10): 1183–5. DOI:10.1016/j.jacc.2015.11.065.
- Boriani G., Savelieva I., Dan G. et al. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society // EP Europace. – 2015; 17 (8): 1169–96. DOI: https://doi.org/10.1093/europace/euv202.
- Potpara T., Jokic V., Dagres N. et al. Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy // Curr. Med. Chem. – 2016; 23 (19): 2070–83. DOI: 10.2174/0929867323666160309114246.
- Alonso A., Lopez F., Matsushita K. et al. Chronic kidney diseaseis associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study // Circulation. – 2011; 123 (25): 2946–53. DOI: 10.1161/CIRCULATIONAHA.111.020982.
- Santoro A., Mancini E., London G. et al. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal // Nephrol. Dial. Transplant. – 2008; 23 (4): 1415–21. DOI: https://doi.org/10.1093/ndt/gfm730.
- Derjugin M.V., Bojtsov S.A. Hronicheskie miokardity / SPb: ELBI-SPb, 2005; 288.
- Papademetriou V. Geometric patterns of left ventricular hypertrophy: Is geometry alone to be blamed? // Hellenic J. Cardiol. – 2017; 58 (2): 143–5. DOI: https://doi.org/10.1016/j.hjc.2017.05.010.
- Houghton J., Prisant L., Carr A. et al. Relationship of left ventricular mass to impairment of coronary vasodilator reserve in hypertensive heart disease // Am. Heart J. – 1991; 121 (4): 1107–12.